You searched for "contact lens"
Mast cells in Graves’ ophthalmopathy
1 August 2016
| Bheemanagouda Patil
|
Ophthalmology
|
Graves’ ophthalmopathy, Histamine, Histamine receptor type-1, Loratadine, Mast cell, NF-κB controlled cytokine, NF-κB inhibitor, Orbital fibroblast
Graves’ ophthalmopathy (GO) is a potentially sight-threatening ocular disease, occurring in patients with hyperthyroidism due to Graves’ disease. Also known as thyroid-associated ophthalmopathy, GO is characterised by orbital infiltration by immune cells including macrophages, T cells and plasma cells, which...
Internuclear ophthalmoplegia: a case study
3 June 2024
| Miguel Kurc
|
Ophthalmology
A 44-year-old patient presents with binocular, mostly horizontal diplopia when fixating on moving objects. This has been ongoing for approximately five years. He is known to have multiple sclerosis and had an episode of optic neuritis six years prior in...
COVID-19: Pete’s Bogus Journey
The author shares his personal experience of contracting coronavirus. I managed to body swerve COVID-19 for nine months. The Pfizer vaccine was being rolled out in my trust. I had my first inoculation booked in three weeks. I had survived...Cricket fan Tony credits NHS cataract surgery with improving his mental health as well as his sight
Tony, 65, could see the ball at Trent Bridge match ‘for the first time in years’ and says ‘everything’ in life has improved, after cataract removal at SpaMedica.Free rail travel for blind and partially sighted people and their companions announced for Scotland
Leading sight loss charities have hailed the Scottish Government’s ‘life changing’ decision to provide free rail travel for blind and partially sighted people and their companions, saying this decision will enhance rehabilitation, independence and ensuring people with vision impairment can maintain links with their communities.Thank you, Baljean Dhillon. Welcome onboard, Peter Cackett.
3 April 2024
| Samuel Verdin
As our Co-editor of over 11 years, Baljean Dhillon, passes the torch, Peter Cackett steps up to take on the role.
An educational review: Teach the Teachers Course
In the ever-changing landscape of medicine, staying up-to-date of the latest developments is essential, especially for specialists such as ophthalmologists.Mike Harris, family optometrist, takes office as Master of The Worshipful Company of Spectacle Makers
Optometrist Mike Harris was installed this week as Master of The Worshipful Company of Spectacle Makers, a fitting culmination to his career supporting better vision for all. Mike qualified with The Worshipful Company of Spectacle Makers in the late 1970s,...Overcoming sight impairment for the Race Across the World!
RNIB’s Tricia travels the world and takes her message that "sight loss doesn’t stop you doing anything" to BBC One.Headset perimetry
3 April 2023
| David Haider
|
Ophthalmology
Visual field analysers are traditionally large table mounted devices, designed specifically for field capture and analysis. Over the last year or so a number of companies have started to disrupt this space with the introduction of headset-based field analysers, mostly...
A Nightmare on Doctor Street: Two
4 October 2023
| Peter Cackett
|
Ophthalmology
Just when you thought it was safe to go back into the clinic room… The quote below comes from Rudy Baylor, a graduate fresh out of law school and recruited by a ruthless ambulance chaser in the legal drama movie,...
Long-term outcome of ALPI for plateau iris syndrome
1 April 2018
| Chrysostomos D Dimitriou
|
Glaucoma
The purpose of this study was to evaluate the long-term outcomes of plateau iris syndrome (PIS) patients treated with argon laser peripheral iridoplasty (ALPI) following YAG laser peripheral iridotomy (LPI). Typical ALPI settings were a spot size of 200 to...